M&A comeback may face political headwinds, say BIO CEO panelists
When it comes to biotech M&A, 2024 wasn’t a great year, but it wasn’t “horrible,” according to analysts at the BIO CEO & Investor […]
M&A comeback may face political headwinds, say BIO CEO panelists Read More »